More than 20 million Americans are currently affected by cataracts, and a new survey from AARP Media Sales and Alcon, the global leader in eye care, found that there are many questions and misperceptions among baby boomers about the condition, their options and how to treat it.
To view Multimedia News Release, go to http://www.multivu.com/mnr/63529-alcon-and-a-a-r-p-mark-world-sight-day-first-live-cataract-education-event
WebMD Health Corp. (Nasdaq: WBMD), the leading source of health information, announced today its new WebMD Allergy app for the iPhone, an innovative new mobile resource that empowers consumers to take control of their allergies. It is the first free app to provide allergy sufferers with personalized location-based allergy condition forecasts in combination with WebMD’s trusted information and insights. WebMD Allergy is further personalized with optional mobile push notifications that warn when allergen levels are high, enabling app users to proactively manage their allergy conditions.
To view Multimedia News Release, go to http://www.multivu.com/mnr/60044-webmd-introduces-new-allergy-app-for-iphone
Eisai Inc. announced today that BELVIQ (pronounced BEL-VEEK) will be available to eligible patients by prescription in the United States beginning June 11.
BELVIQ was approved by the U.S. Food and Drug Administration on June 27, 2012 to be used along with a reduced-calorie diet and increased physical activity for chronic weight management in adults who have a body mass index (BMI) of 30 kg/m² or greater (obese), or BMI of 27 kg/m² or greater (overweight) with at least one weight-related medical condition such as high blood pressure, high cholesterol, or type 2 diabetes. It is not known if BELVIQ is safe and effective when taken with other prescription, over-the-counter, or herbal weight loss products, nor is it known if BELVIQ changes your risk of heart problems or stroke, or of death due to heart problems or stroke.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/60316-eisai-belviq-civ-chronic-weight-management-tablets-for-overweight-adults
Most people are deficient in vitamin D3. You can supplement with 2000, 5000, or 10,000 IU of vitamin D3 but that may not be enough. The only way to tell if your blood has an adequate amount of D3 is to have a blood test for D3 and have your doctor examine the results.
There is only one choice when it come to nutrition that slows down kidney disease and helps joint problems at the same time - The Hill's Science Diet K/D + Mobility.
Learn more here: https://tier1petproducts.com/best-dog-food-for-kidney-disease/
Chronic kidney disease (CKD) is a condition often associated with advanced age. According to recent data 1 out of 10 dogs will develop CKD in his lifetime.
It is also common for senior dogs to develop other age-related conditions such as reduced mobility or cognitive dysfunction which can significantly impact the quality of life of both the pet and the pet parent.
Nutrition can play a key role in managing these age-related conditions. That is why Hill’s nutritionists and veterinarians developed new Prescription Diet K/D + Mobility for dogs.
L’Oréal announced the winners of its International Awards for Social Responsibility in Dermatology, “Caring to Inspire Skin Confidence” at the 23rd World Congress of Dermatology taking place in Vancouver, Canada.
For Asia-Pacific
Dr. Jeong Chan-woo from South Korea
Sharing skin love - Skin Health Promotion for Orphanage and for low-income children/youth
This initiative was established to help children from low-income families, without parents or those living away from their parents, to receive education on how to prevent skin diseases. They also have access to high quality treatment if they are suffering from a dermatological condition.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7554651-loreal-announces-2015-awardees/
L’Oréal announced the winners of its International Awards for Social Responsibility in Dermatology, “Caring to Inspire Skin Confidence” at the 23rd World Congress of Dermatology taking place in Vancouver, Canada.
For Africa and Arab States
Prof. Khalid Mohammed AlGhamdi from Saudi Arabia
Charity Society known as Faal to empower and support vitiligo patients in Saudi Arabia
Vitiligo is a long-term skin condition that causes pale, white patches on the skin due to a lack of melanin. This project aimed to increase awareness via TV broadcasts, schools visits and to provide psychological and social support to patients with vitiligo through training courses and different education programs.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7554651-loreal-announces-2015-awardees/
L’Oréal announced the winners of its International Awards for Social Responsibility in Dermatology, “Caring to Inspire Skin Confidence” at the 23rd World Congress of Dermatology taking place in Vancouver, Canada.
For North America
Dr. Danielle Marcoux from Canada
Camp Liberté – Summer camp for children with skin disorders
This one-week summer camp run by volunteer dermatologists and nurses enrolled children aged 7 to 12 with moderate-to-severe skin disorders, as well as their families, to bring them together for support, social interaction and to increase their confidence. All the activities aim to increase patients’ confidence and self-esteem, improve social skills, reduce stigma about their condition and improve adherence to treatment.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7554651-loreal-announces-2015-awardees/
Following FDA approval of the AspireSR® generator for the VNS Therapy® system in June 2015, more than a thousand patients with drug-resistant epilepsy across the United States have received this new treatment option. Many of these patients are experiencing benefits which have positively impacted their lives – and are sharing their stories during Epilepsy Awareness Month with the hope of encouraging others to seek new treatments for drug-resistant epilepsy. Numerous hospitals nationwide have begun providing the AspireSR device to patients with drug-resistant epilepsy – a condition that affects as many as one-third of people with epilepsy, causing them to have seizures in spite of treatment with antiepileptic medications.
The VNS Therapy system is a minimally invasive option in which a medical device is placed under the skin in the upper chest area during an outpatient procedure. The device sends mild electrical pulses through the vagus nerve to areas of the brain known to be associated with seizures. The new AspireSR generator takes the VNS Therapy technology a step further – detecting relative heart-rate increases that are often associated with seizures in people with epilepsy and providing responsive stimulation in an attempt to stop and shorten seizures and improve recovery.
To view the multimedia release go to:
http://www.multivu.com/players/English/7651751-livanova-aspiresr-treatment/
The latest lash breakthrough is here. From Rimmel, you can get the Moroccan Argan oil your hair loves in a Rimmel mascara with new Wonder’lash Mascara with Argan Oil. Condition lashes and break through clumps for full, smooth volume. The unique brush’s super-soft bristles hug and coat each lash, perfectly separating them from root to tip. Even small corner lashes are dramatically transformed for an effortlessly eye-catching look. Lashes are left smoother, sleeker, and more defined than ever.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7428651-rimmel-london-wonder-lash/
Next week at the Consumer Electronics Showcase (CES) in Las Vegas, Neutrogena® will debut sophisticated skin imaging technology that allows consumers to measure what’s happening above and below their skin’s surface. The Neutrogena Skin360™ app and the accompanying SkinScanner powered by FitSkin™ give users an in depth understanding of their skin’s condition and needs, customized advice to address those needs, plus a clear way to track and assess skin’s progress over time.
“Shopping for skincare products can be an overwhelming and confusing experience for our consumer because she is uncertain about what her skin really needs,” said Sebastien Guillon, Global President of Beauty, Johnson & Johnson Consumer. “Smart and connected technology helps us provide our consumer with personalized analyses and information she needs in real time so she can make decisions that will help her achieve her best skin ever.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8250251-neutrogena-skin360-skinscanner-fitskin-ces/
Nationally-recognized and long-standing sports announcer Jerry Punch, M.D., is teaming up with Men’s Health Network and Endo Pharmaceuticals Inc., a subsidiary of Endo International plc (NASDAQ: ENDP) (TSX: ENL), to launch “Ask About the Curve,” a new educational campaign designed to raise awareness of Peyronie’s disease. Peyronie’s disease is a little-known men’s health condition that can occur during midlife or later. And, while the disease is physical in nature, the impact may also be psychological and could possibly hold men back from talking about it.
Peyronie’s disease, or “PD,” is a condition that can cause curvature of the penis that could be painful during arousal and intimacy. It can affect as many as one in 10 men worldwide, but diagnosis rates remain low because men with PD may be too uncomfortable to speak up and get help. Together with Endo and Men’s Health Network, Dr. Punch is encouraging men who think they might have PD to face their challenge head on by starting the conversation with their doctor.
“As a sports commentator, I’ve witnessed thousands of men on the court, on the field and on the racetrack in their physical prime – cool, confident and thriving in the face of challenge. But, as a licensed physician, I’ve seen how this bravado can turn to embarrassment – even isolation – when that challenge becomes personal or intimate,” said Dr. Punch. “Often, men feel too awkward to talk about issues like Peyronie’s disease, even with a doctor. And while it may seem tough, it’s important that any man with PD see a doctor, and ask about the curve. Starting the conversation is the first step to getting help.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7752151-ask-about-the-curve-psa/
